AMICOSANTE, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 30.191
EU - Europa 2.996
AS - Asia 2.895
SA - Sud America 397
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 36.533
Nazione #
US - Stati Uniti d'America 30.124
SG - Singapore 1.464
DE - Germania 1.077
CN - Cina 681
UA - Ucraina 393
BR - Brasile 329
RU - Federazione Russa 293
IT - Italia 259
IE - Irlanda 254
HK - Hong Kong 225
FR - Francia 224
VN - Vietnam 222
GB - Regno Unito 115
SE - Svezia 115
FI - Finlandia 111
KR - Corea 86
JP - Giappone 53
IN - India 41
CA - Canada 40
PL - Polonia 40
AR - Argentina 27
BD - Bangladesh 27
RO - Romania 27
BE - Belgio 16
ZA - Sudafrica 16
EC - Ecuador 15
AT - Austria 13
MX - Messico 13
BG - Bulgaria 11
ES - Italia 11
ID - Indonesia 11
IQ - Iraq 11
NL - Olanda 10
CO - Colombia 9
KG - Kirghizistan 9
TR - Turchia 9
CL - Cile 8
EU - Europa 8
IL - Israele 7
UZ - Uzbekistan 7
AU - Australia 6
TH - Thailandia 6
MY - Malesia 5
EG - Egitto 4
KE - Kenya 4
PE - Perù 4
PH - Filippine 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
PR - Porto Rico 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
BB - Barbados 2
BS - Bahamas 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
TW - Taiwan 2
ZM - Zambia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
SI - Slovenia 1
SV - El Salvador 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 36.533
Città #
Woodbridge 9.446
Wilmington 7.870
Houston 7.304
Ann Arbor 714
Fairfield 655
Singapore 630
Ashburn 428
Jacksonville 374
Beijing 303
Chandler 302
San Jose 289
Seattle 282
Dublin 244
Hong Kong 220
Cambridge 219
Medford 187
Dearborn 152
New York 116
Santa Clara 95
Lawrence 87
The Dalles 70
Ho Chi Minh City 69
Rome 66
Los Angeles 63
Menlo Park 63
Hanoi 57
Lauterbourg 55
Dallas 54
Zhengzhou 53
Council Bluffs 45
Tokyo 42
Buffalo 38
Guangzhou 37
Milan 35
Mülheim 27
San Diego 27
Kraków 25
São Paulo 25
Helsinki 23
Norwalk 20
Redondo Beach 20
Moscow 19
Chicago 18
Shanghai 18
Nanjing 17
Boardman 16
London 15
Munich 15
Brussels 14
Denver 14
Falls Church 14
Mountain View 14
Rio de Janeiro 14
Hefei 13
Orem 13
Palo Alto 13
Nuremberg 12
University Park 12
Warsaw 12
Atlanta 11
Frankfurt am Main 11
Montreal 11
San Mateo 11
Verona 11
Johannesburg 10
San Francisco 10
Stockholm 10
Chennai 9
Redwood City 9
Sofia 9
Toronto 9
Belo Horizonte 8
Columbus 8
Da Nang 8
Detroit 7
Haiphong 7
Mcallen 7
Mumbai 7
Nanchang 7
North Bergen 7
Phoenix 7
Quito 7
Boston 6
Campinas 6
Melbourne 6
Porto Alegre 6
Pune 6
Tashkent 6
Vienna 6
Auburn Hills 5
Brasília 5
Brooklyn 5
Cape Town 5
Fortaleza 5
Fuzhou 5
Guayaquil 5
Hangzhou 5
Indiana 5
Kunming 5
Ribeirão Preto 5
Totale 31.392
Nome #
Role of individual's T cell immunome in controlling HIV-1 progression 603
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay 603
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 555
B-Pred, a structure based B-cell epitopes prediction server 538
HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations 523
Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model 513
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 506
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 492
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 490
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 485
Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy 483
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 479
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 476
An outbreak of Q fever in Bulgaria 465
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 463
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 459
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 456
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 453
Amino Acid Mutations in Ebola Virus Glycoprotein of the 2014 epidemic 452
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 449
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 444
Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins 444
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study 441
Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption 439
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 439
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 435
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon. 435
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 433
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 433
Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients 433
Key role of human leukocyte antigen in modulating HIV progression: an overview of the possible applications. 433
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport 430
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy 430
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 429
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 428
Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins 427
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis 426
Dynamics of the laboratory results in patients with pulmonary tuberculosis. 424
Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection 423
Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction 422
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 421
Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis 419
Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. 419
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 419
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 415
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 414
Beryllium disease 412
Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis 409
Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte assay for monitoring HIV-specific immunity 408
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 401
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 400
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 400
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 399
IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor? 398
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis 398
Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis 398
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 393
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 391
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 390
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 389
Metal-induced diffuse lung disease 387
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 383
[Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value] 383
[Mycobacterium tuberculosis. From the gene to the diagnosis] 382
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 382
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 381
Method of antigenic peptide identification and relative use for the preparation of a vaccine anti HIV-1 380
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 377
Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding 377
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis 376
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 376
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 372
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 372
Major histocompatibility locus genetic markers of beryllium sensitization and disease 371
Seroprevalence of Ebola virus infection in Bombali district, Sierra Leone 367
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 361
Rapid immunological test for the diagnosis and monitoring of tuberculosis infection. 361
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 359
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 350
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 350
T cell recognition in chronic beryllium disease 342
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 341
Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. 338
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 320
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 319
Metodo e test diagnostici basati sull’analisi citofluorimetrica dei linfociti T antigene-specifici. 277
Occurrence of Legionella in showers at recreational facilities 208
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns 145
Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey|Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial 129
Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation 70
Totale 36.620
Categoria #
all - tutte 72.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202137 0 0 0 0 0 0 0 0 0 0 0 37
2021/2022790 30 82 22 59 21 92 43 40 52 59 65 225
2022/2023867 104 55 29 104 67 242 91 40 71 1 43 20
2023/2024289 47 6 16 12 17 101 7 2 21 4 2 54
2024/20252.043 80 424 214 91 40 75 153 101 202 149 279 235
2025/20262.836 247 174 385 275 240 95 287 346 403 237 86 61
Totale 36.620